Latest News

1News Report – Medsafe Approves 10 Minute Ocrevus Injection

April 30, 2025 | Advocacy, Life with MS, Media, News, Treatments

Watch Graham Walker, person with MS, President of MS Taranaki and Co-Vice President of MSNZ discuss the life-changing news that Medsafe has approved the 10 minute Ocrevus injection, accompanied with comments from Amanda Rose, MSNZ National Manager on 1News, 29th […]


Ocrelizumab Subcut Receives Medsafe Registration as Pressure Mounts to Fund Wider Range of MS Treatment Options

April 24, 2025 | Advocacy, Life with MS, News, Treatments

Photo by Kristine Wook, Unsplash. Medsafe have approved the registration of Ocrevus ® Subcutaneous (SC) (ocrelizumab and hyaluronidase) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). The announcement on […]


MSNZ President Calls for Pharmac to Fund 4 New Drugs on TVNZ Breakfast

March 27, 2025 | Advocacy, Event, Media, News, Treatments

Watch MSNZ President, Neil Woodhams, on TVNZ Breakfast today where he calls for Pharmac to fund 4 new drugs for MS treatment. Neil Woodhams attended this interview ahead of us appearing at Parliament later this morning, with the Bangers to Bluff […]


Our Focus and What’s Next?

February 25, 2025 | Advocacy, News, Treatments

Over the last decade, we have seen the needs of people with MS are changing. This is largely due to the availability of higher efficacy DMTs in NZ, and ever-advancing research is also telling us even more about the importance […]


Are you on an Infusion Treatment?

May 30, 2024 | Advocacy, Treatments

At MSNZ we would like to understand more about patient experiences with infusion treatments. The first line Disease Modifying Treatment (DMT) options we have been successful in advocating for in NZ are considered some of the best in the world. […]